A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. - Wikidata - awgldk - TriplyDB

A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.

A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.

http://www.wikidata.org/entity/Q36086759

about

Clinical Relevance of HLA Gene Variants in HBV Infection Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP New loci associated with chronic hepatitis B virus infection in Han Chinese The impact of host genetic variation on infection with HIV-1.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.Human genes involved in hepatitis B virus infection.Structural and regulatory diversity shape HLA-C protein expression levels.Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population.HLA genotypes and rubella vaccine immune response: additional evidence.High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese Population MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach.Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.Epigenetic regulation of differential HLA-A allelic expression levels.HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.High HLA-DP Expression and Graft-versus-Host Disease.HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients.Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population.Novel HLA-DP region susceptibility loci associated with severe acute GvHD.Host genetic variants influencing the clinical course of hepatitis B virus infection.A genomic perspective on HLA evolution.Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.High-throughput next-generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run.Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.Mismatched unrelated donor transplantation.Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis In celebration of Ruggero Ceppellini: HLA in transplantation.HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population.Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C.Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.Hepatitis B virus and host factors.HLA class II associated with outcomes of hepatitis B and C infections.HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.The immunogenetics of neurological disease.HLA genotyping by next-generation sequencing of complementary DNA.

P2860

Q26744457-A4B1F5BD-2E11-49A2-8484-83578AA80FDA Q28086834-ACABE7DC-73C1-4928-B9B0-4DC04BE33B81 Q28300932-BCCB2A43-ABF1-4AFD-A6AA-6FDA7C1872B9 Q30374810-52307598-AE76-41E9-8FAE-9B037C5D7641 Q33642419-AB9331B6-00EF-44ED-B16B-95DEDD855D8E Q33773772-2EC68CBD-F25C-40E6-8FEB-75102A9DFDB7 Q33801320-1F2F77CD-B855-4060-9B72-0F29B2975BD9 Q33851012-8C2AAC25-9CCD-47C7-A318-6FF1AE266B09 Q33907605-EED226FA-A453-4971-A397-0568C2EA0EFB Q34014935-CF0FDAF2-CEA8-417D-A839-E92852E2322E Q34333656-217F7680-9367-419C-8B25-DCE57BE3AEB0 Q34348786-64FE7CA6-C1DB-4AB1-A235-147D1F9C00C6 Q34509937-40DF17D7-B7E9-477E-91F8-7382CF009401 Q34568890-326FA24E-FEB6-46AF-90F1-1C2D64625CD6 Q35152765-57DCB70C-4E55-4FD2-BA92-B4FF26EE576D Q35821131-5D49BA8F-7FFB-469C-889E-CAD46506801F Q36003331-4D998BD7-B8FF-4E4D-B239-C57A9D7E3EF2 Q36028056-2ED32C45-B483-4C57-BD38-27907A45BE33 Q37254285-A185BB41-5D8D-47B8-875A-D35983EBB114 Q37281576-517CB155-A444-4A3C-83A0-F906D132D68A Q37504645-A5952379-A601-4C28-B0EB-AA4F73019784 Q37509782-6FA63038-2EA9-4F7C-AF4E-9DEAA2E230D5 Q37559942-15DC3846-80FA-420C-AE91-EC133F9C53AA Q38563251-4AE3DAB0-523A-485C-BBA8-59978B9ED499 Q38688783-76B85CEC-2955-4CCA-868C-D75B492E8197 Q38950010-FF725407-AC75-40AC-8099-36C983927B1A Q38983113-3E7ADE70-34D8-4EB9-B8C0-CCAAC6458F11 Q38985750-35D9330C-2A02-4D61-B570-56B663F8B2D1 Q38992834-1AA3A50A-C58E-4D1D-BC73-BE0C2032067F Q39059159-04B1F32B-734D-4202-8F8D-CCECE08A3090 Q39094693-DBEF143C-A196-4C4C-952E-2DE0B3141955 Q39219822-3EEA7907-B6C3-4C9C-BBB0-2BD4F7DFA3AE Q39533880-D31C1A3B-9AE5-415F-A66D-78E9D876067D Q40279001-DA0C47AF-9B3D-48EE-85B3-4E63FA4960E3 Q41621344-881BD538-4323-43BF-BC3F-65B467902172 Q41955691-49CCC9BD-AB9D-40D8-B10E-65F4AE656F72 Q42582521-55A261A9-E7AE-4F02-9479-389A5259CE35 Q45172386-DDB4E25C-3B19-430F-8B01-990E84A0A5F7 Q46094020-9E6CBDC3-8FED-4565-96B2-8207234D81B6 Q47148549-366B9C6F-9C95-4679-899C-B8E81BD01CE0

P2860

A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.

http://www.wikidata.org/entity/Q36086759

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@ast

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@en

type

label

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@ast

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@en

prefLabel

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@ast

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@en

P1433

Q36086759-92E13C01-6CE0-44E3-B9CF-E5669BC3000D

P1476

Q36086759-4E38A223-A48A-40B7-B938-66C05775A6BC

P2093

Q36086759-199C7809-093F-46C2-BDC8-317FCB99B730

Q36086759-1BA056AE-CD12-4473-9120-EC3858C5417F

Q36086759-483A045A-243D-428A-9A6A-15D84A8A3C7A

Q36086759-57E25257-D88D-442A-8EDE-10DFA02B83C8

Q36086759-5CD94426-86A0-46E1-A198-A6EACAF65C87

Q36086759-708693C8-4E90-4C60-BA93-8BD947BDF8D0

Q36086759-A419C172-4E8E-4326-BFE3-ACCA91BCCB02

Q36086759-B0A8B80B-144A-4C5F-861F-814C248534EA

Q36086759-B78DE280-65AC-4816-804A-C05DF08CF625

Q36086759-CE38689D-A465-4333-A70B-8DB269C76D9B

P2860

Q36086759-08912371-EFB4-4232-89AF-A41E79F4F5E4

Q36086759-2D7291D4-8A91-40D7-A271-7DB6F9794A84

Q36086759-3620BE26-630B-49F2-9C5F-4092A7C1F2B1

Q36086759-3C4CFED8-9C87-41DD-ADD4-50DF92BFFA22

Q36086759-41DE94A4-9975-4FA3-BB5F-4571163F3499

Q36086759-4AD441A9-C58F-4E35-BE8B-32BDF9189EA0

Q36086759-4F8AEF3A-6F37-41A5-BFDF-2101E1ED2F56

Q36086759-5588DB3D-1829-40DE-AADF-6A3FFACB41F8

Q36086759-7D96B135-1CAB-42B7-9977-20362A3AEEFC

Q36086759-84F8832B-35AE-4FA5-902C-B7C85818E41F

P304

Q36086759-514AC0D0-88DE-4BCF-AB87-219A55FDC76F

P31

Q36086759-ED3EBF82-74C3-4DF8-80CA-977AAD247E25

P356

Q36086759-9E737E86-F449-4B6D-AF00-E55AA674BF93

P407

Q36086759-68A52B1B-4C57-4C9F-97E4-588E90A5B8FD

P433

Q36086759-2B640AF9-4849-49A1-A34F-775A392FA739

P478

Q36086759-88D0615A-7AEB-47DA-A537-6D82DF5EB812

P50

Q36086759-7EE1EF7D-44A9-4283-AEE0-C160487E6E05

P577

Q36086759-73671CAA-705D-444D-89C4-593C23F8B6E2

P5875

Q36086759-D8D39D51-EC4C-4707-BEAD-94113892DE16

P698

Q36086759-F2705B6F-F3D6-4C29-A6A2-33F99DB1A798

P932

Q36086759-48898101-9DD1-49FA-9EA3-C9ED0D520775

P356

P1433

Journal of Virology

P1476

A novel variant marking HLA-DP ...... m hepatitis B virus infection.

@en

P2093

Chloe L Thio

http://www.w3.org/2001/XMLSchema#string

Darlene Marti

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

Judy L Stein

http://www.w3.org/2001/XMLSchema#string

Kelly A Soderberg

http://www.w3.org/2001/XMLSchema#string

M Anthony Moody

http://www.w3.org/2001/XMLSchema#string

Rasmi Thomas

http://www.w3.org/2001/XMLSchema#string

Richard Apps

http://www.w3.org/2001/XMLSchema#string

Steven Wolinsky

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A new mathematical model for relative quantification in real-time RT-PCR

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Class II HLA alleles and hepatitis B virus persistence in African Americans.

HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.

Molecular virology of hepatitis B virus.

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

P304

6979-6985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00406-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

P577

2012-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223977492

http://www.w3.org/2001/XMLSchema#string

P698

22496224

http://www.w3.org/2001/XMLSchema#string

P932

3393572

http://www.w3.org/2001/XMLSchema#string